Link hormones with motor fluctuations
- Trial ID
- NCT06582212
- Official Title
- Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers
- Goal
- Link hormones with motor fluctuations
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University Hospital, Grenoble
- Study Type
- INTERVENTIONAL
- Enrollment
- 100 participants
- Conditions
- Digital Technology, Mobile Application, Motor Fluctuations, Oestrogen, Parkinson Disease
- Interventions
- Mymovesmatter mobile application
Plain-Language Summary
The trial is helping women with Parkinson's see whether hormonal changes are linked to motor fluctuations, so they can better predict and manage symptom ups and downs. Participants use the Mymovesmatter mobile app to track menstrual cycles, hormonal treatments like OCP or IUD, and daily motor symptoms, and the app looks for patterns that could inform timing of levodopa or other treatment and lifestyle discussions with clinicians; the app itself does not change medications. It's enrolling non-menopausal women aged 18 to 56 with Parkinson's diagnosed at least two years ago who are on a stable PD medication regimen and able to give informed consent; post-menopausal women and those with conditions preventing safe participation are excluded.
Locations
- CHU Grenoble Alpes, Grenoble, Grenoble, France
- CHU Nantes Hôpital Laennec, Nantes, France
- CHU Rennes -Site Pontchaillou, Rennes, France
- Chu Toulouse, Toulouse, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Mymovesmatter mobile application. The trial is helping women with Parkinson's see whether hormonal changes are linked to motor fluctuations, so they can better predict and manage symptom ups and downs. Participants use the Mymovesmatter mobile app to track menstrual cycles, hormonal treatments like OCP or IUD, and daily motor symptoms, and the app looks for patterns that could inform timing of levodopa or other treatment and lifestyle discussions with clinicians; the app itself does not change medications. It's enrolling non-menopausal women aged 18 to 56 with Parkinson's diagnosed at least two years ago who are on a stable PD medication regimen and able to give informed consent; post-menopausal women and those with conditions preventing safe participation are excluded.
- Who can participate?
- Participants must be between 18 Years and 56 Years.
- Where is this trial located?
- This trial is recruiting at 4 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.